Screening of three synthetic organic trivalent antimonials for potential antischistosomal activity in mice.
D000818:Animals; D000965:Antimony / Q000494:pharmacology / Q000633:toxicity*; D007928:Lethal Dose 50; D051379:Mice; D009942:Organometallic Compounds; D011743:Pyrimidines; D012550:Schistosoma mansoni / Q000187:drug effects; D012552:Schistosomiasis / Q000188:drug therapy; D012556:Schistosomicides
D009942:Organometallic Compounds; D011743:Pyrimidines; D012556:Schistosomicides; C029545:antimonyl-7-formyl-8-hydroxyquinoline-5-sulphonate; C029542:antimonyl-2,4-dihydroxy-5-hydroxymethylpyrimidine; C029541:antimonyl-2,4-dihydroxypyrimidine; D000965:Antimony